Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 2
2018 2
2019 3
2020 2
2021 7
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
Koshkin VS, Henderson N, James M, Natesan D, Freeman D, Nizam A, Su CT, Khaki AR, Osterman CK, Glover MJ, Chiang R, Makrakis D, Talukder R, Lemke E, Olsen TA, Jain J, Jang A, Ali A, Jindal T, Chou J, Friedlander TW, Hoimes C, Basu A, Zakharia Y, Barata PC, Bilen MA, Emamekhoo H, Davis NB, Shah SA, Milowsky MI, Gupta S, Campbell MT, Grivas P, Sonpavde GP, Kilari D, Alva AS. Koshkin VS, et al. Among authors: natesan d. Cancer. 2022 Mar 15;128(6):1194-1205. doi: 10.1002/cncr.34057. Epub 2021 Dec 9. Cancer. 2022. PMID: 34882781
BODIPY Fluorophores for Membrane Potential Imaging.
Franke JM, Raliski BK, Boggess SC, Natesan DV, Koretsky ET, Zhang P, Kulkarni RU, Deal PE, Miller EW. Franke JM, et al. Among authors: natesan dv. J Am Chem Soc. 2019 Aug 14;141(32):12824-12831. doi: 10.1021/jacs.9b05912. Epub 2019 Aug 6. J Am Chem Soc. 2019. PMID: 31339313 Free PMC article.
Definitive Chemoradiotherapy for Vulvar Cancer.
Natesan D, Susko M, Havrilesky L, Chino J. Natesan D, et al. Int J Gynecol Cancer. 2016 Nov;26(9):1699-1705. doi: 10.1097/IGC.0000000000000811. Int J Gynecol Cancer. 2016. PMID: 27575629
A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer.
Hathout L, Wang Y, Wang Q, Vergalasova I, Elshaikh MA, Dimitrova I, Damast S, Li JY, Fields EC, Beriwal S, Keller A, Kidd EA, Usoz M, Jolly S, Jaworski E, Leung EW, Donovan E, Taunk NK, Chino J, Natesan D, Russo AL, Lea JS, Albuquerque KV, Lee LJ. Hathout L, et al. Among authors: natesan d. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1423-1431. doi: 10.1016/j.ijrobp.2021.02.055. Epub 2021 Mar 5. Int J Radiat Oncol Biol Phys. 2021. PMID: 33677053
TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor.
de Kouchkovsky I, Zhang L, Philip EJ, Wright F, Kim DM, Natesan D, Kwon D, Ho H, Ho S, Chan E, Porten SP, Wong AC, Desai A, Huang FW, Chou J, Oh DY, Pruthi RS, Fong L, Small EJ, Friedlander TW, Koshkin VS. de Kouchkovsky I, et al. Among authors: natesan d. J Immunother Cancer. 2021 May;9(5):e002127. doi: 10.1136/jitc-2020-002127. J Immunother Cancer. 2021. PMID: 33980590 Free PMC article.
18 results